Annual Net Margin
-2054.76%
+2710.83%+56.88%
31 December 2023
Summary:
Celldex Therapeutics annual net profit margin is currently -2054.76%, with the most recent change of +2710.83% (+56.88%) on 31 December 2023. During the last 3 years, it has fallen by -1248.88% (-154.97%). CLDX annual net margin is now -37880.78% below its all-time high of -5.41%, reached on 31 December 2010.CLDX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
-1319.99%
+114.84%+8.00%
01 September 2024
Summary:
Celldex Therapeutics quarterly net profit margin is currently -1319.99%, with the most recent change of +114.84% (+8.00%) on 01 September 2024. Over the past year, it has increased by +1202.09% (+47.66%). CLDX quarterly net margin is now -2297.05% below its all-time high of 60.08%, reached on 31 December 2010.CLDX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +56.9% | +47.7% |
| 3 y3 years | -155.0% | +90.1% |
| 5 y5 years | -29.6% | +36.9% |
CLDX Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -155.0% | +56.9% | -25.9% | +94.0% |
| 5 y | 5 years | -155.0% | +56.9% | -243.5% | +94.0% |
| alltime | all time | <-9999.0% | +56.9% | -2297.1% | +94.0% |
Celldex Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -1319.99%(-8.0%) |
| June 2024 | - | -1434.83%(-93.2%) |
| Mar 2024 | - | -21.03 K%(+1906.1%) |
| Dec 2023 | -2054.76%(-56.9%) | -1048.32%(-58.4%) |
| Sept 2023 | - | -2522.08%(-77.8%) |
| June 2023 | - | -11.38 K%(+274.8%) |
| Mar 2023 | - | -3036.30%(+84.9%) |
| Dec 2022 | -4765.59%(+214.3%) | -1642.10%(-75.0%) |
| Sept 2022 | - | -6580.84%(-70.2%) |
| June 2022 | - | -22.09 K%(+66.7%) |
| Mar 2022 | - | -13.25 K%(+119.6%) |
| Dec 2021 | -1516.04%(+88.1%) | -6032.34%(-54.9%) |
| Sept 2021 | - | -13.37 K%(+3378.5%) |
| June 2021 | - | -384.28%(-84.1%) |
| Mar 2021 | - | -2414.31%(+317.3%) |
| Dec 2020 | -805.88%(-43.4%) | -578.60%(-72.8%) |
| Sept 2020 | - | -2129.34%(-54.4%) |
| June 2020 | - | -4674.15%(+910.0%) |
| Mar 2020 | - | -462.79%(-60.7%) |
| Dec 2019 | -1423.96%(-10.2%) | -1177.79%(-43.7%) |
| Sept 2019 | - | -2090.29%(+26.9%) |
| June 2019 | - | -1647.41%(+36.2%) |
| Mar 2019 | - | -1209.75%(+126.9%) |
| Dec 2018 | -1585.07%(+117.1%) | -533.05%(-30.7%) |
| Sept 2018 | - | -769.71%(+29.6%) |
| June 2018 | - | -593.81%(-79.6%) |
| Mar 2018 | - | -2903.93%(+2512.9%) |
| Dec 2017 | -730.06%(-61.5%) | -111.14%(-83.5%) |
| Sept 2017 | - | -671.84%(-9.9%) |
| June 2017 | - | -746.04%(-66.6%) |
| Mar 2017 | - | -2233.44%(+29.5%) |
| Dec 2016 | -1894.05%(-18.4%) | -1724.88%(+29.4%) |
| Sept 2016 | - | -1333.24%(-42.0%) |
| June 2016 | - | -2300.36%(-13.6%) |
| Mar 2016 | - | -2661.01%(+45.8%) |
| Dec 2015 | -2321.11%(-29.5%) | -1824.90%(-41.5%) |
| Sept 2015 | - | -3116.96%(+109.8%) |
| June 2015 | - | -1485.72%(-76.1%) |
| Mar 2015 | - | -6208.64%(+188.2%) |
| Dec 2014 | -3292.81%(+66.0%) | -2154.50%(-15.5%) |
| Sept 2014 | - | -2550.59%(-46.6%) |
| June 2014 | - | -4776.01%(-33.6%) |
| Mar 2014 | - | -7188.22%(+102.0%) |
| Dec 2013 | -1983.70%(+275.9%) | -3558.39%(+50.7%) |
| Sept 2013 | - | -2361.22%(-88.0%) |
| June 2013 | - | -19.60 K%(+2630.5%) |
| Mar 2013 | - | -717.98%(+55.8%) |
| Dec 2012 | -527.79%(+9.2%) | -460.84%(-4.5%) |
| Sept 2012 | - | -482.72%(-29.6%) |
| June 2012 | - | -685.57%(+23.4%) |
| Mar 2012 | - | -555.53%(+6.2%) |
| Dec 2011 | -483.53%(+8837.7%) | -523.09%(+5.0%) |
| Sept 2011 | - | -498.18%(-5.0%) |
| June 2011 | - | -524.39%(+31.2%) |
| Mar 2011 | - | -399.80%(-765.4%) |
| Dec 2010 | -5.41%(-97.8%) | 60.08%(-115.9%) |
| Sept 2010 | - | -377.37%(+16.9%) |
| June 2010 | - | -322.77%(+82.1%) |
| Mar 2010 | - | -177.27%(-35.2%) |
| Dec 2009 | -240.61%(-62.2%) | -273.46%(+53.6%) |
| Sept 2009 | - | -178.01%(-45.1%) |
| June 2009 | - | -324.21%(+57.1%) |
| Mar 2009 | - | -206.40%(-17.2%) |
| Dec 2008 | -637.08%(-40.6%) | -249.38%(-23.2%) |
| Sept 2008 | - | -324.67%(-37.9%) |
| June 2008 | - | -523.07%(-96.5%) |
| Mar 2008 | - | -15.01 K%(+1261.3%) |
| Dec 2007 | -1072.36%(-45.9%) | -1102.91%(-26.9%) |
| Sept 2007 | - | -1508.33%(+233.5%) |
| June 2007 | - | -452.27%(-83.8%) |
| Mar 2007 | - | -2799.50%(+71.9%) |
| Dec 2006 | -1983.49%(+238.5%) | - |
| Sept 2006 | - | -1628.49%(+45.2%) |
| June 2006 | - | -1121.77%(+1299.4%) |
| Mar 2006 | - | -80.16%(-87.2%) |
| Dec 2005 | -585.96%(+204.4%) | -627.41%(+17.6%) |
| Sept 2005 | - | -533.42%(-28.2%) |
| June 2005 | - | -742.97%(+48.1%) |
| Mar 2005 | - | -501.62%(+244.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2004 | -192.51%(-29.6%) | -145.79%(-79.2%) |
| Sept 2004 | - | -700.88%(+60.5%) |
| June 2004 | - | -436.60%(+593.0%) |
| Mar 2004 | - | -63.00%(-86.5%) |
| Dec 2003 | -273.47%(+32.6%) | -467.31%(+345.1%) |
| Sept 2003 | - | -104.99%(-64.4%) |
| June 2003 | - | -295.19%(-40.1%) |
| Mar 2003 | - | -493.21%(+15.1%) |
| Dec 2002 | -206.26%(-69.7%) | -428.60%(+6972.6%) |
| Sept 2002 | - | -6.06%(-99.2%) |
| June 2002 | - | -803.41%(+13.0%) |
| Mar 2002 | - | -711.19%(-2.9%) |
| Dec 2001 | -680.03%(-76.4%) | -732.65%(-14.6%) |
| Sept 2001 | - | -857.89%(+25.2%) |
| June 2001 | - | -685.43%(+47.1%) |
| Mar 2001 | - | -466.08%(-89.6%) |
| Dec 2000 | -2879.32%(+277.7%) | -4474.17%(+89.5%) |
| Sept 2000 | - | -2361.01%(+33.4%) |
| June 2000 | - | -1769.92%(+28.2%) |
| Mar 2000 | - | -1380.62%(+59.3%) |
| Dec 1999 | -762.33%(-68.4%) | - |
| Sept 1999 | - | -866.67%(+206.2%) |
| June 1999 | - | -283.05%(-68.5%) |
| Mar 1999 | - | -900.00%(+311.0%) |
| Dec 1998 | -2408.85%(+119.2%) | -218.96%(-98.1%) |
| Sept 1998 | - | -11.70 K%(+2600.0%) |
| June 1998 | - | -433.33%(+23.8%) |
| Mar 1998 | - | -350.00%(-8.5%) |
| Dec 1997 | -1098.90%(+11.9%) | -382.56%(-95.2%) |
| Sept 1997 | - | -8000.00%(+3194.1%) |
| June 1997 | - | -242.86%(-87.2%) |
| Mar 1997 | - | -1900.00%(+137.5%) |
| Dec 1996 | -981.82%(+373.2%) | -800.00%(-65.2%) |
| Sept 1996 | - | -2300.00%(+7.0%) |
| June 1996 | - | -2150.00%(+578.9%) |
| Mar 1996 | - | -316.67%(+1325.2%) |
| Dec 1995 | -207.50%(+25.2%) | -22.22%(-94.3%) |
| Sept 1995 | - | -387.50%(+78.8%) |
| June 1995 | - | -216.67%(+8.3%) |
| Mar 1995 | - | -200.00%(-54.5%) |
| Dec 1994 | -165.71%(+91.2%) | -440.00%(+120.0%) |
| Sept 1994 | - | -200.00%(+91.3%) |
| June 1994 | - | -104.55%(+26.6%) |
| Mar 1994 | - | -82.61%(-17.4%) |
| Dec 1993 | -86.67%(+58.9%) | -100.00%(-12.5%) |
| Sept 1993 | - | -114.29%(+98.1%) |
| June 1993 | - | -57.69%(-25.3%) |
| Mar 1993 | - | -77.27%(+103.7%) |
| Dec 1992 | -54.55%(+5.5%) | - |
| Oct 1992 | - | -37.93%(-24.1%) |
| July 1992 | - | -50.00%(-14.3%) |
| Apr 1992 | - | -58.33%(+352.2%) |
| Apr 1992 | -51.69%(+55.1%) | - |
| Jan 1992 | - | -12.90%(-85.4%) |
| Oct 1991 | - | -88.24%(+15.4%) |
| July 1991 | - | -76.47%(+112.4%) |
| Apr 1991 | -33.33%(+263.5%) | -36.00%(+17.0%) |
| Jan 1991 | - | -30.77%(+14.3%) |
| Oct 1990 | - | -26.92%(-32.7%) |
| July 1990 | - | -40.00%(-553.5%) |
| Apr 1990 | -9.17%(-35.0%) | 8.82%(-130.2%) |
| Oct 1989 | - | -29.17%(+2.1%) |
| July 1989 | - | -28.57%(-756.8%) |
| Apr 1989 | -14.10%(-46.0%) | 4.35%(-116.5%) |
| Jan 1989 | - | -26.32%(+25.0%) |
| Oct 1988 | - | -21.05%(+19.3%) |
| July 1988 | - | -17.65%(-52.9%) |
| Apr 1988 | -26.09%(-28.2%) | -37.50%(+87.5%) |
| Jan 1988 | - | -20.00%(+20.0%) |
| Oct 1987 | - | -16.67%(-58.3%) |
| July 1987 | - | -40.00%(-73.3%) |
| Apr 1987 | -36.36%(-97.9%) | -150.00%(+1100.0%) |
| Jan 1987 | - | -12.50%(-25.0%) |
| Oct 1986 | - | -16.67%(-88.9%) |
| July 1986 | - | -150.00%(-75.0%) |
| Apr 1986 | -1700.00% | - |
| Jan 1986 | - | -600.00%(+50.0%) |
| Oct 1985 | - | -400.00%(+33.3%) |
| July 1985 | - | -300.00% |
FAQ
- What is Celldex Therapeutics annual net profit margin?
- What is the all time high annual net margin for Celldex Therapeutics?
- What is Celldex Therapeutics annual net margin year-on-year change?
- What is Celldex Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly net margin year-on-year change?
What is Celldex Therapeutics annual net profit margin?
The current annual net margin of CLDX is -2054.76%
What is the all time high annual net margin for Celldex Therapeutics?
Celldex Therapeutics all-time high annual net profit margin is -5.41%
What is Celldex Therapeutics annual net margin year-on-year change?
Over the past year, CLDX annual net profit margin has changed by +2710.83% (+56.88%)
What is Celldex Therapeutics quarterly net profit margin?
The current quarterly net margin of CLDX is -1319.99%
What is the all time high quarterly net margin for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly net profit margin is 60.08%
What is Celldex Therapeutics quarterly net margin year-on-year change?
Over the past year, CLDX quarterly net profit margin has changed by +1202.09% (+47.66%)